A potential metabolic-targeted therapeutic for Amyotrophic lateral sclerosis (ALS): Leptin

Project: Research

Project Details

StatusFinished
Effective start/end date15/09/2019 → 14/09/2022

Collaborative partners

  • King's College London
  • Research Unit of the National Hospital for Paraplegics (lead)
  • CEU San Pablo University
  • University of Tasmania

Funding

  • La Caixa Foundation: £10,249.90